couter

LVX.VLeviathan Gold Ltd.

Oct 20, 2026 — Fall Exploration Program Assay Results
Chart by TradingView

The schedule

  • Tue20Oct

    Junior gold explorers trade entirely on drill bit success during periods of adequate capitalization. This catalyst represents the release of crucial assay results from the fall exploration program, which will dictate whether the asset can spike from the $0.18 base price to the $0.35 target or collapse to the $0.12 fallback.

  • Sat31Oct

    The Q2 2026 report will serve as a referendum on the summer's financial engineering. If the company successfully secured runway, the market will shift focus back to the fundamental asset value, aiming for the $0.40 target from the $0.28 base price. Failure to demonstrate a stabilized balance sheet will trigger further capitulation toward the $0.18 fallback.

  • Sat28Nov

    Q3 2026 results will detail year-end liquidity and budget requirements for the 2027 exploration season. Investors will be highly reactive to the updated management guidance on operational spend, determining whether the stock can reclaim the $0.22 target from a $0.12 base price or fade to the $0.08 fallback.

  • Fri30Apr

    Full-year 2026 earnings combined with a comprehensive resource estimate update. By this point, Leviathan Gold will either have proven a commercially viable deposit warranting a relief rally from the $0.08 base price to the $0.18 target, or will face terminal delisting pressures near the $0.05 fallback.

Past

  • Sat25Jul

    To cure the structural cash deficit, Leviathan is highly likely to execute a dilutive equity offering. Given the $0.40 base price assumption and 125% annualized volatility, any capital raise will likely price at a steep discount, pressing the valuation to the $0.28 fallback rather than the $0.48 target.